Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: If If If

If If If

posted on Feb 08, 2010 08:00PM

This is one of those "If" extrapolations. And, it's worth every penny you paid for it.

If there are 500 companies that will buy a license during the next 5 years,

and if PTSC nets on average $2, 000,000 per license,

PTSC would net $1 billion in the next 5 years, or an average of $200 million per year. That's over 50 cents per share in earnings. With a PE ratio of only 10 we'd have a share priced of $5.00.

Some pretty conservative assumptions it would seem. Now I remember why I bought this stock. The dream continues.

5
Feb 08, 2010 08:25PM
3
Feb 08, 2010 11:57PM
Share
New Message
Please login to post a reply